Horsham, United Kingdom

Benjamin Richard Bellenie

USPTO Granted Patents = 3 


Average Co-Inventor Count = 8.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: The Innovations of Benjamin Richard Bellenie

Introduction

Benjamin Richard Bellenie is a notable inventor based in Horsham, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. With a total of 3 patents to his name, Bellenie's work is recognized for its potential impact on medical treatments.

Latest Patents

Bellenie's latest patents include innovative compounds designed as phosphatidylinositol 3-kinase inhibitors. The first patent focuses on amino pyridine derivatives that inhibit the activity of the PI 3-kinase gamma isoform. This invention is particularly useful for treating diseases that are mediated by the activation of this isoform. The second patent presents amino pyrazine derivatives with similar inhibitory effects on the PI 3-kinase gamma isoform, further emphasizing the therapeutic potential of these compounds.

Career Highlights

Bellenie is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other talented professionals in the field, enhancing the scope and impact of his inventions. His dedication to research and innovation has positioned him as a key figure in pharmaceutical development.

Collaborations

Some of Bellenie's notable coworkers include Ian Bruce and Andrew James Culshaw. Their collaborative efforts contribute to the advancement of research and the successful development of new therapeutic compounds.

Conclusion

Benjamin Richard Bellenie's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments, showcasing the importance of research and collaboration in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…